Table 4.
Scenario | PAP | Non-PAP | Difference |
---|---|---|---|
5% scenario | |||
Cost to payer | $36,287 | $36,134 | $153 |
Total QALYs | 0.63 | 0.62 | 0.01 |
10% scenario | |||
Cost to payer | $36,440 | $36,134 | $307 |
Total QALYs | 0.64 | 0.62 | 0.01 |
15% scenario | |||
Cost to payer | $36,594 | $36,134 | $460 |
Total QALYs | 0.64 | 0.62 | 0.02 |
20% scenario | |||
Cost to payer | $36,747 | $36,134 | $614 |
Total QALYs | 0.65 | 0.62 | 0.03 |
25% scenario | |||
Cost to payer | $36,901 | $36,134 | $767 |
Total QALYs | 0.66 | 0.62 | 0.03 |
Notes: Each scenario refers to the percentage of patients in the PAP arm on pemetrexed vs BSC at the start of the model. All patients in the non-PAP arm are assigned to BSC.
Abbreviations: PAP, patient assistance program; QALYs, quality-adjusted life years; BSC, basic standard care.